VNDA · Categories · Form 4

VNDA - SEC Form 4 insider transactions

Vanda Pharmaceuticals Inc. (VNDA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for VNDA

• 1d
  SVP, GC and Secretary Mcguire Daniel Patrick was granted 80,000 shares, increasing direct ownership by 267% to 109,982 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1d
  Director Chrousos Phaedra was granted 41,600 shares, increasing direct ownership by 34% to 164,950 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1d
  Director Duncan Charles Cliff was granted 41,600 shares, increasing direct ownership by 73% to 98,701 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1d
  Director Dugan Richard W was granted 41,600 shares, increasing direct ownership by 23% to 219,054 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1d
  Director Ward Anne Sempowski was granted 41,600 shares, increasing direct ownership by 35% to 160,667 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1d
  Director Honore Tage was granted 41,600 shares, increasing direct ownership by 45% to 135,069 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1d
  Director Mitchell Stephen Ray was granted 41,600 shares, increasing direct ownership by 58% to 112,846 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 20d
  Director Mitchell Stephen Ray gifted 25,836 shares, decreasing direct ownership by 27% to 71,246 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 46d
  Director Duncan Charles Cliff was granted 57,101 shares (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 97d
  SVP & General Counsel Williams Timothy sold $350,755 worth of shares (42,434 units at $8.27), decreasing direct ownership by 10% to 377,450 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 97d
  SVP, CFO & Treasurer Moran Kevin Patrick sold $350,821 worth of shares (42,442 units at $8.27), decreasing direct ownership by 9% to 411,380 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 97d
  SVP, Chief Marketing Officer Wijkstrom Joakim sold $254,590 worth of shares (30,800 units at $8.27), decreasing direct ownership by 8% to 333,469 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 97d
  President and CEO Polymeropoulos Mihael Hristos sold $1,276,971 worth of shares (156,235 units at $8.17), decreasing direct ownership by 5% to 2,704,496 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 97d
  SVP, Business Development Birznieks Gunther sold $350,730 worth of shares (42,431 units at $8.27), decreasing direct ownership by 8% to 494,197 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 105d
  Director Honore Tage sold $240,900 worth of shares (30,000 units at $8.03), decreasing direct ownership by 24% to 93,469 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 110d
  SVP, Chief Marketing Officer Wijkstrom Joakim was granted 125,000 shares, increasing direct ownership by 52% to 364,269 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 110d
  SVP, Business Development Birznieks Gunther was granted 125,000 shares, increasing direct ownership by 30% to 536,628 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 110d
  SVP & General Counsel Williams Timothy was granted 125,000 shares, increasing direct ownership by 42% to 419,884 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 110d
  SVP, CFO & Treasurer Moran Kevin Patrick was granted 125,000 shares, increasing direct ownership by 38% to 453,822 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 110d
  President and CEO Polymeropoulos Mihael Hristos was granted 525,000 shares, increasing direct ownership by 22% to 2,860,731 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 358d
  Director Mitchell Stephen Ray sold $32,130 worth of shares (7,000 units at $4.59), decreasing direct ownership by 7% to 97,082 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 365d
  Director Mitchell Stephen Ray was granted 59,225 shares, increasing direct ownership by 132% to 104,082 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 365d
  Director Chrousos Phaedra was granted 59,225 shares, increasing direct ownership by 92% to 123,350 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 365d
  Director Dugan Richard W was granted 59,225 shares, increasing direct ownership by 50% to 177,454 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 365d
  Director Honore Tage was granted 59,225 shares, increasing direct ownership by 92% to 123,469 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 365d
  Director Ward Anne Sempowski was granted 59,225 shares, increasing direct ownership by 99% to 119,067 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 462d
  SVP, Chief Marketing Officer Wijkstrom Joakim covered exercise/tax liability with 15,520 shares, decreasing direct ownership by 6% to 239,269 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 462d
  SVP, Business Development Birznieks Gunther covered exercise/tax liability with 26,941 shares, decreasing direct ownership by 6% to 411,628 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 462d
  SVP, CFO & Treasurer Moran Kevin Patrick covered exercise/tax liability with 26,941 shares, decreasing direct ownership by 8% to 328,822 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 462d
  SVP & General Counsel Williams Timothy covered exercise/tax liability with 26,941 shares, decreasing direct ownership by 8% to 294,884 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 474d
  SVP, Chief Marketing Officer Wijkstrom Joakim was granted 125,000 shares, increasing direct ownership by 96% to 254,789 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 474d
  President and CEO Polymeropoulos Mihael Hristos was granted 450,000 shares, increasing direct ownership by 24% to 2,321,730 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 474d
  SVP, CFO & Treasurer Moran Kevin Patrick was granted 125,000 shares, increasing direct ownership by 55% to 353,763 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 474d
  SVP, Business Development Birznieks Gunther was granted 125,000 shares, increasing direct ownership by 40% to 438,569 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 474d
  SVP & General Counsel Williams Timothy was granted 125,000 shares, increasing direct ownership by 64% to 321,825 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 568d
  Director Mitchell Stephen Ray sold $25,863 worth of shares (5,000 units at $5.17), decreasing direct ownership by 10% to 44,857 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 680d
  SVP, CFO & Treasurer Moran Kevin Patrick sold $13,327 worth of shares (2,251 units at $5.92), decreasing direct ownership by 0.97% to 228,763 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 746d
  Chrousos Phaedra was granted 21,887 shares, increasing direct ownership by 52% to 64,125 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 749d
  Honore Tage was granted 20,529 shares, increasing direct ownership by 47% to 64,244 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 749d
  Dugan Richard W was granted 20,529 shares, increasing direct ownership by 21% to 118,229 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 749d
  Mitchell Stephen Ray was granted 20,529 shares, increasing direct ownership by 70% to 49,857 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 749d
  Ward Anne Sempowski was granted 20,529 shares, increasing direct ownership by 52% to 59,842 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 825d
  Wijkstrom Joakim sold $71,921 worth of shares (16,727 units at $4.30), decreasing direct ownership by 11% to 129,789 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 825d
  Williams Timothy sold $73,313 worth of shares (17,088 units at $4.29), decreasing direct ownership by 8% to 196,825 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 825d
  Birznieks Gunther sold $73,379 worth of shares (17,411 units at $4.21), decreasing direct ownership by 5% to 313,569 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 825d
  Moran Kevin Patrick sold $63,393 worth of shares (14,700 units at $4.31), decreasing direct ownership by 6% to 231,014 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 825d
  Polymeropoulos Mihael Hristos sold $231,339 worth of shares (55,172 units at $4.19), decreasing direct ownership by 3% to 1,871,730 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 839d
  Williams Timothy was granted 125,000 shares, increasing direct ownership by 141% to 213,913 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 839d
  Polymeropoulos Mihael Hristos was granted 450,000 shares, increasing direct ownership by 30% to 1,926,902 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 839d
  Moran Kevin Patrick was granted 125,000 shares, increasing direct ownership by 104% to 245,714 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 839d
  Wijkstrom Joakim was granted 32,700 shares, increasing direct ownership by 29% to 146,516 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 839d
  Birznieks Gunther was granted 125,000 shares, increasing direct ownership by 61% to 330,980 units (SEC Form 4)

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1021d
  SEC Form 4: Wijkstrom Joakim sold $21,748 worth of shares (3,724 units at $5.84), decreasing direct ownership by 3% to 113,816 units

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1033d
  SEC Form 4: Mitchell Stephen Ray sold $39,349 worth of shares (6,500 units at $6.05), decreasing direct ownership by 18% to 29,328 units

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1043d
  SEC Form 4: Moran Kevin Patrick sold $13,945 worth of shares (2,212 units at $6.30), decreasing direct ownership by 2% to 120,714 units

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1085d
  SEC Form 4 filed by Moran Kevin Patrick

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1090d
  SEC Form 4 filed by Williams Timothy

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1093d
  SEC Form 4 filed by Ward Anne Sempowski

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1093d
  SEC Form 4 filed by Mitchell Stephen Ray

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)
• 1093d
  SEC Form 4 filed by Honore Tage

  4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)

Other VNDA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends